This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
This article is about what happens when people with cirrhosis are not part of a screening program for liver cancer.
Child-Pugh B and C, and elevated alpha-fetoprotein, at diagnosis of hepatocellular carcinoma corresponded with a diagnosis outside Milan criteria and surveillance failure during a surveillance program of patients with cirrhosis.
“HCC surveillance in cirrhotic patients aims to detect tumors in the initial stages of the disease to offer treatments that increase patient survival,” Alejo Mancebo, MD,from the Hospital Universitario Central de Asturias, Spain, and colleagues wrote. “Although the usefulness of screening programs remains controversial, several studies have shown survival improvement in patients under surveillance.”